Literature DB >> 16257164

Sirtuin 1 (SIRT1) sequence variation is not associated with exceptional human longevity.

Friederike Flachsbart1, Peter J P Croucher, Susanna Nikolaus, Jochen Hampe, Christina Cordes, Stefan Schreiber, Almut Nebel.   

Abstract

The SIR2/Sirt1 gene has been demonstrated as regulating lifespan in many model organisms, including yeast, Caenorhabditis elegans and rodents. These findings render the human homologue, SIRT1, a very plausible candidate as a modifier of human life expectancy. We therefore sought to investigate whether common allelic variation in the SIRT1 gene was associated with human longevity. Five single nucleotide polymorphisms (SNPs), distributed across the entire gene, including the promoter region, were genotyped in our extensive DNA collections of 1573 long-lived individuals (centenarians and nonagenarians) and matched younger controls. Four of the markers were haplotype-tagging SNPs (htSNPs) that defined five common haplotypes. No evidence for an association was detected between any of the tested SNPs and the longevity phenotype at the allele, genotype or haplotype levels. These findings, based on an htSNP approach, suggest that there is no noteworthy influence of SIRT1 sequence variation on exceptional human longevity in the German population. However, this does not rule out the possibility that allelic variants in direct regulators or downstream substrates of SIRT1 could play critical roles in extending lifespan in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257164     DOI: 10.1016/j.exger.2005.09.008

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  34 in total

1.  Evidence from case-control and longitudinal studies supports associations of genetic variation in APOE, CETP, and IL6 with human longevity.

Authors:  Mette Soerensen; Serena Dato; Qihua Tan; Mikael Thinggaard; Rabea Kleindorp; Marian Beekman; H Eka D Suchiman; Rune Jacobsen; Matt McGue; Tinna Stevnsner; Vilhelm A Bohr; Anton J M de Craen; Rudi G J Westendorp; Stefan Schreiber; P Eline Slagboom; Almut Nebel; James W Vaupel; Kaare Christensen; Lene Christiansen
Journal:  Age (Dordr)       Date:  2012-01-12

Review 2.  Sirtuin activators and inhibitors.

Authors:  José M Villalba; Francisco J Alcaín
Journal:  Biofactors       Date:  2012-06-25       Impact factor: 6.113

Review 3.  Genetic epidemiology in aging research.

Authors:  M Daniele Fallin; Amy Matteini
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-23       Impact factor: 6.053

Review 4.  Genetic and epigenetic regulation of human aging and longevity.

Authors:  Brian J Morris; Bradley J Willcox; Timothy A Donlon
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-01       Impact factor: 5.187

5.  Targeting sirtuins for the treatment of diabetes.

Authors:  Frank K Huynh; Kathleen A Hershberger; Matthew D Hirschey
Journal:  Diabetes Manag (Lond)       Date:  2013-05-01

Review 6.  Sirtuin 1 and sirtuin 3: physiological modulators of metabolism.

Authors:  Ruben Nogueiras; Kirk M Habegger; Nilika Chaudhary; Brian Finan; Alexander S Banks; Marcelo O Dietrich; Tamas L Horvath; David A Sinclair; Paul T Pfluger; Matthias H Tschöp
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

7.  Respected Sir(2): magic target for diabetes.

Authors:  Pratibha V Nerurkar; Vivek R Nerurkar
Journal:  Cellscience       Date:  2008-04-27

Review 8.  Sirtuins as regulators of metabolism and healthspan.

Authors:  Riekelt H Houtkooper; Eija Pirinen; Johan Auwerx
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-07       Impact factor: 94.444

Review 9.  SIRT1 regulation modulates stroke outcome.

Authors:  Valérie Petegnief; Anna M Planas
Journal:  Transl Stroke Res       Date:  2013-08-15       Impact factor: 6.829

10.  SIRT1 promoter polymorphisms as clinical modifiers on systemic lupus erythematosus.

Authors:  Camila Rosat Consiglio; Schauren Juliana da Silveira; Odirlei André Monticielo; Ricardo Machado Xavier; João Carlos Tavares Brenol; José Artur Bogo Chies
Journal:  Mol Biol Rep       Date:  2014-02-26       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.